These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24690948)

  • 1. Plasma IGFBP-2 levels after postoperative combined radiotherapy and chemotherapy predict prognosis in elderly glioblastoma patients.
    Han S; Meng L; Han S; Wang Y; Wu A
    PLoS One; 2014; 9(4):e93791. PubMed ID: 24690948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
    Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
    Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas.
    Lin Y; Jiang T; Zhou K; Xu L; Chen B; Li G; Qiu X; Jiang T; Zhang W; Song SW
    Neuro Oncol; 2009 Oct; 11(5):468-76. PubMed ID: 19164435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme.
    Abdolhoseinpour H; Mehrabi F; Shahraki K; Khoshnood RJ; Masoumi B; Yahaghi E; Goudarzi PK
    J Neurol Sci; 2016 Jul; 366():202-206. PubMed ID: 27288807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.
    Gorlia T; van den Bent MJ; Hegi ME; Mirimanoff RO; Weller M; Cairncross JG; Eisenhauer E; Belanger K; Brandes AA; Allgeier A; Lacombe D; Stupp R
    Lancet Oncol; 2008 Jan; 9(1):29-38. PubMed ID: 18082451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
    Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
    J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
    Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
    World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of removed tumor volume and location on patient outcome in glioblastoma.
    Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
    J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute.
    Uzuka T; Aoki H; Natsumeda M; Takahashi H; Fujii Y
    Neurol Med Chir (Tokyo); 2012; 52(8):570-6. PubMed ID: 22976140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer.
    Liou JM; Shun CT; Liang JT; Chiu HM; Chen MJ; Chen CC; Wang HP; Wu MS; Lin JT
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1717-25. PubMed ID: 20157191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short course of radiation therapy in elderly patients with glioblastoma multiforme.
    Idbaih A; Taillibert S; Simon JM; Psimaras D; Schneble HM; Lopez S; Lang P; Toubiana T; Feuvret L; Delattre JY; Mazeron JJ
    Cancer Radiother; 2008 Dec; 12(8):788-92. PubMed ID: 19046921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and functional status after resection of recurrent glioblastoma multiforme.
    Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
    Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors.
    Boulle N; Baudin E; Gicquel C; Logié A; Bertherat J; Penfornis A; Bertagna X; Luton JP; Schlumberger M; Le Bouc Y
    Eur J Endocrinol; 2001 Jan; 144(1):29-36. PubMed ID: 11174834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
    Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
    Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
    Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
    Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.